Improve Vaccine Trial Enrollment With Better Site Recruitment Planning
About this webinar
Recruitment planning in vaccine research does not follow the same approach as most other clinical trials. It presents unique challenges related to participant populations, disease patterns and site capabilities. This webinar explores why vaccine trial recruitment differs and how research teams can develop recruitment and adherence plans that remain effective as conditions change.
Unlike many therapeutic studies, vaccine trials enroll healthy volunteers rather than patients already in care. These participants have no treatment need that brings them to a site, so recruitment depends on community trust, convenient access and clear communication about the study. Large cohorts also strain site capacity and extend enrollment timelines. The same applies after vaccination: study procedures may continue for months, with adherence essential to collecting the data needed to meet primary and secondary objectives.
Timing and place matter as much as numbers. Disease incidence, seasonality and local outbreaks shape where and when a study can succeed, requiring recruitment plans to adapt to changing epidemiology. Regulatory pathways, consent requirements and participant motivation also vary across regions and countries, particularly in low- and middle-income countries (LMICs). Local expertise is therefore essential for site selection, feasibility assessment and enrollment projections.
Diversity, hesitancy and adherence add another layer. Enrolling a representative vaccine population willing to follow months-long study procedures requires early community engagement and realistic participation expectations. Planning for these factors early reduces the risk of disruptive mid-study adjustments.
Attendees will learn practical approaches to set realistic enrollment targets, assess site feasibility, track recruitment progress and adjust strategies when enrollment diverges from projections. A real-world example will highlight a Phase II pediatric vaccine study across 17 sites in seven Latin American countries and Puerto Rico, where local pediatrician referral networks and tailored on-site outreach helped achieve 102% of the enrollment target despite post-pandemic hesitancy.
Register for this webinar to learn how to strengthen recruitment and adherence planning for vaccine clinical trials, set realistic enrollment targets and adapt recruitment strategies to changing study conditions.
Who should attend
- Clinical Operations
- Clinical Development and Vaccine Development
- Recruitment, Enrollment and Participant Engagement
- Feasibility and Site Selection
- Clinical Project and Program Management
- Biostatistics and Epidemiology
- Community Engagement and Public Health Programs
- Infectious Disease and Vaccine Research Leads
- Site Management and Research Site Networks
What you will learn
- Why recruitment planning behaves differently in vaccine research, particularly when enrolling large cohorts of healthy volunteers
- How disease incidence, seasonality and geography shape site selection, enrollment pace and timelines
- Practical ways to engage diverse communities and address hesitancy during recruitment
- How to establish realistic recruitment plans and adjust early when enrollment diverges from the plan
Featured Speakers
Jarina Sutkó
Jarina Sutkó is a Physician and Pharmacist with more than 15 years of experience in clinical research. She has worked across monitoring, clinical operations, feasibility and strategic site partnerships at leading global CROs and a top pharma company. She is Director, Head of Site and Patient Access at Emmes. She leads global teams that harmonize feasibility, strengthen investigator and site relationships and help sponsors choose the right countries and sites. Her work gives sponsors realistic data-driven projections and enrolment plans, as well as providing access to patient populations that clinical trials rarely reach.
Ute Bertelsmann
Ute Bertelsmann is the Managing Director and Country Head of Pratia Germany, where she leads a network of six dedicated research sites with extensive experience in vaccination research. Supported by a team with decades of experience, Pratia Germany operates in one of eight countries within the Pratia Network. Pratia operates across Europe and the US.
Before joining Pratia, Ute gained experience with various health-related companies. She began her career as an Editor at a medical publishing company before spending several years running her own agency specializing in auditive pharma marketing and working as a freelance Project Manager for large pharma companies. In 2017, Ute entered the field of clinical research as a Business Developer and spent the COVID-19 pandemic working with two start-ups. She holds an MA from Freie Universität in Berlin, with a focus on literature and linguistics.
Partner for this event
VaxTrials part of Emmes Group
VaxTrials is Emmes CRO’s vaccine and infectious disease (VID) center of excellence. With over 35 years in business, operations in more than 90 countries and a record of 400+ clinical trials managed and 350+ journal articles co-authored, our work has contributed to a number of important vaccines being licensed.
Our team’s experience, understanding of local regulatory landscapes and solid network of experienced investigators, supported by Emmes Group’s technology and AI capabilities, enable fast startup, efficient recruitment and high adherence to quality standards.
Our mission is to contribute to public health by accelerating the path to eradicating preventable diseases. In close partnership with our clients, we aim to be at the forefront of global health challenges. Together, we are shaping a healthier future.